Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
56 Results Found
340B Advocacy Alliance Bulletin - July 29, 2025
Register for Aug. 1 AHA Site-neutral Advocacy Alliance Call.
AHA 340B Advocacy Alliance Newsletter
The Department of Health and Human Services today issued a notice announcing a 340B Rebate Model Pilot Program as a voluntary mechanism for qualifying drug manufacturers to effectuate the 340B ceiling price on select drugs to all 340B covered entities.
AHA 340B Advocacy Alliance Bulletin - AHA Regulatory Advisory on 340B Rebate Pilot Program
The Health Resources and Services Administration (HRSA) July 31 announced a 340B rebate model pilot program that will provide certain drugmakers the option to effectuate access to 340B discounted pricing for certain drugs under a rebate model.
340B Advocacy Alliance Bulletin - June 13, 2025
AHA Post-Acute Care Advocacy Alliance News Update - June 13, 2025
AHA 340B Advocacy Alliance Bulletin: HRSA Issues Final Warning to J&J on 340B Proposal
The Health Resources and Services Administration today sent a final warning letter to Johnson & Johnson urging the company to inform the agency by Monday, Sept. 30 that it would halt its proposed 340B rebate model scheduled to go into effect next month.
340B Advocacy Alliance Bulletin - April 24, 2025
340B Advocacy Alliance Bulletin for April 24, 2025.
AHA 340B Advocacy Alliance
The AHA Feb. 28 filed a friend-of-the-court brief in the U.S. District Court for the District of Columbia, urging the court to uphold the Health Resources and Services Administration’s decision to reject Johnson & Johnson’s proposed 340B rebate model in a lawsuit brought by J&J to bar the agency from doing so.
340B AHA Advocacy Alliance - March 7, 2025
AHA, others file amicus briefs opposing major drug companies’ 340B rebate models
AHA 340B Advocacy Alliance - January 6, 2025
AHA 340B Advocacy Alliance Bulletin for January 6, 2025.